Miconazole revisited: new evidence of antifungal efficacy from laboratory and clinical trials

Future Microbiology
Andrei Barasch, Andreea Voinea Griffin

Abstract

In the past 40 years imidazoles have been used extensively in medicine for their antifungal properties. All members of the azole antifungal family inhibit ergosterol biosynthesis. However, the discovery of an additional fungicidal mode of action for miconazole has drawn renewed attention to this compound. In this article we review recent evidence of mechanistic efficacy, as well as clinical trial results of miconazole in new topical formulations.

References

Jan 1, 1995·Pharmacology & Therapeutics·H Vanden BosscheH Moereels
Sep 15, 1996·Annals of Internal Medicine·M WeinertD P Lynch
Aug 1, 1996·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·L Bunetel, M Bonnaure-Mallet
Dec 22, 1999·AIDS Research and Human Retroviruses·W G PowderlyJ R Perfect
Apr 19, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John H RexJohn E Edwards
Aug 16, 2001·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·L L PattonD A Shugars
May 11, 2002·Critical Reviews in Oral Biology and Medicine : an Official Publication of the American Association of Oral Biologists·A N Ellepola, L P Samaranayake
Sep 18, 2002·Antimicrobial Agents and Chemotherapy·Daisuke KobayashiNaoki Watanabe
Dec 31, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter G PappasInfectious Diseases Society of America
Apr 7, 2006·Expert Review of Anti-infective Therapy·Annette W Fothergill
Apr 25, 2006·Journal of Oral Rehabilitation·K YoshidaY Igarashi
Sep 23, 2006·Thérapie·Bertrand Dupont
Jun 8, 2007·The Journal of Biological Chemistry·Karin ThevissenIsabelle E J A François

Citations

Jan 21, 2012·Toxicological Sciences : an Official Journal of the Society of Toxicology·Kyung-Jong WonBokyung Kim
Nov 15, 2011·Photochemistry and Photobiology·Sara B SnellConstantine G Haidaris
May 10, 2012·Expert Opinion on Pharmacotherapy·Gérald E PiérardClaudine Piérard-Franchimont
Jan 26, 2010·Expert Opinion on Drug Delivery·Carmen Alvarez-LorenzoAngel Concheiro
Sep 15, 2009·International Journal of Antimicrobial Agents·Emilia SiikalaRiina Rautemaa
Jun 12, 2012·Journal of Biomaterials Applications·Nhung T T DangAllan G A Coombes
Jun 30, 2018·Experimental Dermatology·Émilie FawayYves Poumay
Jun 10, 2009·Expert Opinion on Pharmacotherapy·Joel M Laudenbach, Joel B Epstein
May 12, 2010·Expert Review of Anti-infective Therapy·Naomi Musaji
Oct 1, 2020·Organic & Biomolecular Chemistry·Sumit GhoshAlakananda Hajra

Related Concepts

Related Feeds

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Expert Opinion on Pharmacotherapy
Pascale QuatresoozGérald E Piérard
Journal of the American Academy of Dermatology
E B Smith
© 2021 Meta ULC. All rights reserved